Mebuki Financial GroupInc Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Mebuki Financial GroupInc şirketinin toplam varlıkları ¥21,282.8B ve toplam öz sermayesi ¥991.9B. Toplam mevduatlar ¥17,686.3B ve toplam krediler ¥12,831.9B olup 0.8% Faiz Marjı kazandırmaktadır. Şu anda toplam kredilerin 1.5% oranında olan kötü krediler için yeterli ödeneği yoktur. Nakit ve kısa vadeli yatırımlar ¥3,481.1B tutarındadır.

Anahtar bilgiler

21.5x

Varlık/özkaynak oranı

0.8%

Net faiz marjı

Toplam mevduat	JP¥17.69t
Kredi/mevduat oranı	Uygun
Batık krediler	1.5%
Sorunlu krediler için ayrılan karşılık	Düşük
Cari oran	Düşük
Nakit ve eşdeğerleri	JP¥3.48t

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Varlık Seviyesi: 5EE 'nin Varlıkların Öz Sermayeye Oranı ( 21.5 x) çok yüksek.

Kötü Krediler İçin Ödenek: 5EE düşük kötü krediler için ödeneke sahiptir ( 42 %).

Düşük Riskli Yükümlülükler: 5EE 'un yükümlülüklerinin 87% 'i esas olarak düşük riskli finansman kaynaklarından oluşmaktadır.

Kredi Seviyesi: 5EE Kredi/Varlık oranı açısından uygun bir seviyeye sahiptir ( 60% ).

Düşük Riskli Mevduatlar: 5EE 'nin Kredi/Mevduat oranı ( 73% ) uygundur.

Kötü Kredilerin Seviyesi: 5EE uygun düzeyde kötü krediler içeriyor ( 1.5 %).

Mebuki Financial GroupInc Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Second quarter 2025 earnings released: EPS: JP¥13.68 (vs JP¥7.55 in 2Q 2024)

Mebuki Financial Group,Inc. (TSE:7167) announces an Equity Buyback for 20,000,000 shares, representing 2% for ¥10,000 million.

Mebuki Financial Group,Inc. to Report Q2, 2025 Results on Nov 11, 2024

Upcoming dividend of JP¥7.00 per share

Investor sentiment deteriorates as stock falls 19%

Final dividend of JP¥7.00 announced

Mebuki Financial Group,Inc. to Report Q1, 2025 Results on Aug 05, 2024

Full year 2024 earnings released: EPS: JP¥41.67 (vs JP¥29.91 in FY 2023)

Mebuki Financial Group,Inc., Annual General Meeting, Jun 26, 2024

Mebuki Financial Group,Inc. (TSE:7167) announces an Equity Buyback for 20,000,000 shares, representing 1.97% for ¥10,000 million.

Mebuki Financial Group,Inc. to Report Fiscal Year 2024 Results on May 10, 2024

Upcoming dividend of JP¥6.00 per share

Third quarter 2024 earnings released: EPS: JP¥8.56 (vs JP¥4.52 in 3Q 2023)

Mebuki Financial Group,Inc. to Report Q3, 2024 Results on Feb 07, 2024

Second quarter 2024 earnings released: EPS: JP¥7.55 (vs JP¥10.72 in 2Q 2023)

Mebuki Financial Group, Inc. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 4, 2023 and Provides Dividend Guidance for the Full Year Ending March 31, 2024

Mebuki Financial Group, Inc. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 4, 2023 and Provides Dividend Guidance for the Full Year Ending March 31, 2024

Mebuki Financial Group,Inc. to Report Q2, 2024 Results on Nov 10, 2023

Upcoming dividend of JP¥5.50 per share at 2.6% yield

First quarter 2024 earnings released: EPS: JP¥14.66 (vs JP¥14.22 in 1Q 2023)

Mebuki Financial Group,Inc. to Report Q1, 2024 Results on Aug 04, 2023

Full year 2023 earnings released: EPS: JP¥29.91 (vs JP¥38.97 in FY 2022)

Mebuki Financial Group,Inc. (TSE:7167) announces an Equity Buyback for 35,000,000 shares, representing 3.29% for ¥10,000 million.

Mebuki Financial Group,Inc., Annual General Meeting, Jun 22, 2023

Upcoming dividend of JP¥5.50 per share at 3.4% yield

Mebuki Financial Group,Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

Mebuki Financial Group,Inc. Provides Consolidated Earnings Forecasts for Fiscal Year 2022 Ending March 31, 2023

Third quarter 2023 earnings released: EPS: JP¥4.52 (vs JP¥12.55 in 3Q 2022)

Mebuki Financial Group,Inc. to Report Q3, 2023 Results on Feb 06, 2023

Second quarter 2023 earnings released: EPS: JP¥10.72 (vs JP¥5.37 in 2Q 2022)

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥10.72 (vs JP¥5.37 in 2Q 2022)

Mebuki Financial Group,Inc. (TSE:7167) announces an Equity Buyback for 20,000,000 shares, representing 1.85% for ¥5,000 million.

Mebuki Financial Group, Inc. to Report Q2, 2023 Results on Nov 11, 2022

Upcoming dividend of JP¥5.50 per share

First quarter 2023 earnings released: EPS: JP¥14.22 (vs JP¥16.63 in 1Q 2022)

Mebuki Financial Group, Inc. Provides Consolidated Earnings Guidance for Six Months Ending September 30, 2022 and Fiscal Year Ending March 31, 2023

Mebuki Financial Group, Inc. to Report Q1, 2023 Results on Aug 04, 2022

Full year 2022 earnings released: EPS: JP¥38.97 (vs JP¥31.45 in FY 2021)

Mebuki Financial Group, Inc. Provides Consolidated Earnings Guidance for the First Half Ending September 30, 2022 and Full Year Ending March 31, 2023

Mebuki Financial Group, Inc., Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Mebuki Financial Group, Inc. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥5.50 per share

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Mebuki Financial Group, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022

Second quarter 2022 earnings released: EPS JP¥11.08 (vs JP¥7.35 in 2Q 2021)

Upcoming dividend of JP¥5.50 per share

First quarter 2022 earnings released: EPS JP¥16.63 (vs JP¥11.29 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥31.45 (vs JP¥31.14 in FY 2020)

Mebuki Financial Group, Inc. (TSE:7167) announces an Equity Buyback for 60,000,000 shares, representing 5.17% for ¥16,000 million.

Upcoming dividend of JP¥5.50 per share

New 90-day high: €1.79

Third quarter 2021 earnings released: EPS JP¥6.79 (vs JP¥11.04 in 3Q 2020)

Mebuki Financial Group, Inc.(TSE:8333) dropped from S&P Japan Mid Cap 100

New 90-day low: €1.55

Mebuki Financial Group, Inc. to Report Q3, 2021 Results on Feb 05, 2021

New 90-day low: €1.60

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Sağlıklı şirketleri keşfedin